Protocol No.: CA057-008
- Title
- A Phase 3, Two-stage, Randomized, Multicenter, Open-label Study Comparing CC-92480 (BMS-986348), Carfilzomib, and Dexamethasone (480Kd) Versus Carfilzomib and Dexamethasone (Kd) in Participants with Relapsed or Refractory Multiple Myeloma (RRMM)
- Principal Investigator
- Safi, Salah Ud Din
- Phase
- III
- Age Group
- Adult
- Applicable Disease Site
- Multiple Myeloma
- Participating Institution
- Mary Babb Randolph Cancer Center
- Contact
- Kathryn Oliverio, LPN
- Research Specialist
- Phone: +1 304-293-7374
- Email: kathryn.oliverio1@hsc.wvu.edu